Manifold + AWS: Accelerating Life Sciences in the AI Era

Transforming How Science Happens

A Strategic Collaboration to Accelerate Discovery

Manifold and AWS share a mission: to help researchers and data teams unlock the full potential of biomedical data.

By combining AWS’s secure, compliant cloud infrastructure with Manifold’s domain-specific AI capabilities, we enable organizations to unify their scientific data, simplify collaboration, and deploy advanced analytics — all within their own AWS environment.

Built on AWS. Trusted by leading institutions across genomics, oncology, and population health.

Why Leading Life Sciences Teams Choose Manifold + AWS

1. Secure and Compliant by Design

Single-tenant deployments within each customer’s AWS account ensure that sensitive data never leaves their control.

Manifold meets or exceeds SOC 2 Type II, HIPAA, GDPR, 21 CFR Part 11, and NIST 800-171 requirements.

2. AI-Native Data Platform

Manifold harmonizes multimodal data into AI-ready structures and provides intelligent agents for discovery, cohort building, and hypothesis testing.

3. Aligned with Enterprise Cloud Strategy

With Bring Your Own Cloud (BYOC) deployment, customers leverage existing AWS investments, enterprise security policies, and pricing benefits — ensuring alignment between scientific innovation and IT governance.

The Results Speak for Themselves

Broad Clinical Labs needed to deliver BGE and WGS sequencing data to customers on AWS, moving beyond simple file delivery. By partnering with Manifold, they now deliver data directly to AWS where customers browse QC data, variants, and files using AI. In addition, their customers can upload phenotypic data that automatically joins with genotype data—delivering far more value than traditional file delivery.

Foundation Medicine needed to accelerate drug development for biopharma partners using their comprehensive 800,000+ patient genomic dataset. FoundationInsights® 2.0, powered by Manifold, enabled this with natural language search and advanced analytics, giving partners a one-stop shop to rapidly identify patient cohorts, explore genomic alterations, and extract insights faster than ever before.

Broad Institute's Spatial Transcriptomics Platform team needed to transform how spatial omics samples are processed and delivered to researchers, moving from manual workflows to an integrated delivery system. By partnering with Manifold, they now process samples, run spatial sequencing workflows, and deliver all outputs directly into a pre-configured workbench with CellDega software, giving researchers immediate access to interactive analysis tools.

Built for Every Stakeholder

For Executives and Data Leaders

  • 99% faster time-to-insight, no additional FTEs
  • 2× research capacity with existing resources
  • Transparent cost governance dashboards

For Scientists and Researchers

  • Unified multimodal data access
  • AI-assisted cohort and feasibility analysis
  • Reproducible R/Python/SAS workbenches

For IT and Compliance Leaders

  • Attribute-based access control and SSO integration
  • Immutable audit trails and lineage tracking
  • Single-tenant, BYOC architecture

Inside the Architecture

A secure Manifold control plane operates inside each customer’s AWS account, integrating seamlessly with services like Amazon S3, HealthOmics, Lake Formation, EC2, and SageMaker.

Data from EMR, LIMS, genomics, imaging, and registry systems is harmonized through AI-assisted pipelines and made accessible through intuitive dashboards, cohort explorers, and high-code workbenches.

This architecture delivers AI-ready data, complete transparency, and full compliance — all within the customer’s own cloud boundary.

Purpose-Built for the Scale and Speed of Modern Research

AWS Capability

Amazon S3 & AWS HealthOmics
Amazon EC2 & AWS Batch
AWS IAM & Lake Formation
AWS Glue & Data Catalog
Amazon SageMaker

Better Together: Broad Institute, AWS, and Manifold

Powering the Next Era of Data-Driven Discovery

The Broad Institute of MIT and Harvard, a world leader in genomics, partnered with AWS and Manifold AI to modernize its data platform and extend the capabilities of its Terra environment. The collaboration was announced live at the AWS Health & Life Sciences Symposium (May 2025), highlighting how cloud and AI are reshaping global biomedical research.

“To meet growing demand driven by the molecularization of medicine and changing customer expectations around cloud and AI, we’ve partnered with AWS and Manifold AI to take this to the next level. Manifold modernizes Broad’s data platform and data science environment by leveraging the latest AWS services to enable scalable, AI-driven research.”

Benjamin Neale

Core Institute Member, Broad Institute of MIT and Harvard

Solutions

Fit-for-purpose solutions for clinical research leaders in cancer and rare disease.

Cancer Observational Study

Streamline legacy systems and manual processes with a single study and data management platform.

Learn more

Cancer Center Biobank

Reduce and turnaround time and increase productivity by connecting biospecimen data and clinical data in a single data management platform.

Learn more

Cancer Center Registry

Unify clinical and multimodal data on a modern platform to enable automated data preparation into a research-ready patient model.

Learn more

Rare Disease Registry

Answer research questions about diagnoses, treatments, and outcomes quickly and easily.

Learn more